University of Leicester
Browse

Use of Eculizumab During Pregnancy in Kidney Transplant Recipients With Atypical HUS

Download (120.37 kB)
journal contribution
posted on 2020-05-22, 08:34 authored by Chee Kay Cheung, Katie J Nettleton, Matthew L Williams, Amy S Page, Yvonne Littler, Andrea Goodlife, Tanu Singhal, Nigel J Brunskill, Susan J Carr
<p>To the Editor: Duvaletal. 1 recently described a kidney transplant recipient who developed atypical hemolytic uremic syndrome, and was treated with eculizumab during pregnancy with a successful outcome. We described a similar case recently (Cheung CK, Evans K, Williams M, et al. A successful pregnancy in a patient following renal transplantation for atypical HUS managed with eculizumab. UK Kidney Week; June 2018. Available at: https://britishrenal.org/ukkw2018-2/abstracts-2/. Accessed September 29, 2019)</p>

History

Related Materials

Citation

Use of Eculizumab During Pregnancy in Kidney Transplant Recipients With Atypical HUS Cheung, Chee Kay et al. Kidney International Reports, Volume 4, Issue 11, 1658

Version

  • VoR (Version of Record)

Published in

Kidney International Reports

Volume

4

Issue

11

Pagination

1658 - 1658 (1)

Publisher

ELSEVIER SCIENCE INC

issn

2468-0249

eissn

2468-0249

Acceptance date

2019-08-12

Copyright date

2019

Spatial coverage

United States

Language

English

Usage metrics

    University of Leicester Publications

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC